More Emerging Biopharma and CROs Adopt Veeva Vault CDMS

Published on: 

Applied Clinical Trials

An increasing number of emerging biopharma companies and contract research organizations (CROs) are adopting Vault CDMS from Veeva Systems to manage their clinical data. More life sciences organizations are using Veeva Vault CDMS for multiple clinical trials to drive greater speed and agility in study execution.

Vault CDMS is a modern cloud application for clinical data management that combines EDC, coding, data cleaning, and reporting on a single cloud platform. 

Vertex Pharmaceuticals Inc. builds studies faster

To support the company’s goal of speeding study start-up, the data management team partnered with Veeva to shorten database build times. They completed their first study build with Vault CDMS in just 8 weeks, 40% faster than their average build times. Their second took only 6 weeks, more than twice as fast as previous study builds. The team aims to further reduce build times to as little as 4 weeks by 2021.

“With Veeva Vault CDMS, we have significantly improved our agility and are building study databases faster than ever before,” said Vikas Gulati, executive director, clinical data management and metrics, Vertex Pharmaceuticals. “Veeva has been a tremendous partner helping us advance our operational efficiency and accelerate trial execution.”


Lotus Clinical Research improves efficiency across study teams

As a CRO and research site specializing in analgesic studies, Lotus Clinical Research needed a modern EDC system that was intuitive and easy to use for data managers and clinical research associates (CRAs). CRAs can view outstanding tasks and data that needs verification to save time when preparing for each site visit, while data managers can eliminate creating manual listings for monitors with automated reporting.

“Veeva Vault CDMS gives our site personnel a user-friendly interface that takes them directly to what’s needed so they no longer have to click through casebooks and find where they left off,” said Jennifer Nezzer, director of biometrics at Lotus Clinical Research. “Automated to-do lists and reports also save our CRAs and data managers hours each week. Veeva has improved the overall experience in how we collect and clean clinical data.”

Cara Therapeutics maintains consistency and control of clinical data

As a small biopharma, Cara Therapeutics outsources its trials to a combination of data management vendors and full-service CROs. The company standardized on Vault CDMS for all the studies included in three of their clinical development projects to drive greater consistency in clinical data management across its partners.

“Veeva Vault CDMS gives us control over our casebooks and consistency in our data when working with different CROs,” said Evelyn Dorsey, associate director of data management, Cara Therapeutics. “We’ve used Veeva Vault CDMS with more than five different CROs and they have all been impressed with the speed of building studies and making mid-study changes.”

“Veeva is proud to partner with the life sciences industry to transform clinical data management,” said Henry Levy, general manager of Veeva Vault CDMS. “There’s been excitement and pent up demand for a modern clinical data management application that can easily run studies of all types. Veeva Vault CDMS can handle the smallest to the most complex studies and get them up and running fast.”